Berry Genomics announced that the controlling shareholder Gao Yang, due to the default of stock pledge, will be reduced by Guosen Securities through centralized bidding of no more than 3.53 million shares, accounting for 1% of the total share capital. The reduction period is within three months after 15 trading days from the date of announcement. This reduction will not lead to a change in the company's controlling rights, nor will it have a significant adverse impact on the company's governance structure and daily operations.
贝瑞基因：控股股东高扬拟被动减持353万股
Berry Genomics: The controlling shareholder Gao Yang plans to passively reduce 3.53 million shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.